Until now, the use of invasive urodynamics with use of catheters is still the gold standard for lower urinary tract evaluation in subjects with CP. This suggests a psychological and physical impact of invasive urodynamics in subjects with CP and further demonstrates the need to avoid standard use of invasive urodynamics in children and adults with CP. The current study will evaluate usefulness of uroflowmetry, correlation between uroflowmetry parameters and different lower urinary tract symptoms will be investigated. Secondly, results of uroflowmetry indicating possible vulnerability of the upper urinary tract will be defined.
A cross-sectional case-control study comparing children with CP and LUTS and children with CP without LUTS will be conducted with the primary objective to investigate correlation between uroflowmetry parameters and different LUTS. Children will be evaluated with uroflowmetry and subsequent post void residual measurement and the validated vancouver symptom score for dysfunctional elimination syndrome.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Enrollment
56
Non-invasive urodynamic measurement wireless uroflowmeter UROCAP™ IV, Goby System Laborie
Ultrasound of post void residual urine bladderscan CUBEscan BioCon 700
Ghent University Hospital
Ghent, Flanders, Belgium
Amount of pathological uroflow patterns - Qualitative assessment
Interpretation by pediatric urologist following ICCS classification Measured during uroflowmetry
Time frame: During cross-sectional testing
Amount of pathological uroflow patterns - Quantitative assessment
Interpretation using Flow index methodology Measured during uroflowmetry
Time frame: During cross-sectional testing
Maximal flow
Measured during uroflowmetry Qmax (mililitres/seconds
Time frame: During cross-sectional testing
Influencing factors for uroflow measurement
* Functional impairment of the child * hip angle * Vancouver symptom score for dysfunctional elimination syndrome
Time frame: During cross-sectional testing
Voided volume
Measured during uroflowmetry mililitres Percentage of expected bladder capacity
Time frame: During cross-sectional testing
Post void residual urine
Measured with CUBEscan BioCon 700 mililiters Percentage of voided volume
Time frame: During cross-sectional testing
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.